BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Staging
730 results:

  • 1. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
    Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
    Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Applicability and feasibility of robot-assisted cystectomy and intracorporeal urinary diversion in a patient with right renal pelvic ectopia.
    Puliatti S; Ferretti S; Peñaranda NR; Eissa A; Ticonosco M; De Faveri A; De Carne C; Wisz P; Ferrari R; Tosi G; Annino F; Bianchi G; Micali S
    Int Braz J Urol; 2024; 50(2):227-228. PubMed ID: 38386794
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development and validation of a nomogram for predicting the impact of tumor size on cancer-specific survival of locally advanced renal cell carcinoma: a SEER-based study.
    Bai J; Lu Q; Wen Y; Shangguan T; Ye Y; Lin J; Liu R; Cai W; Chen J
    Aging (Albany NY); 2024 Feb; 16(4):3823-3836. PubMed ID: 38376430
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
    Saal J; Bald T; Eckstein M; Ralser DJ; Brossart P; Ellinger J; Hölzel M; Klümper N
    Lung Cancer; 2024 Mar; 189():107505. PubMed ID: 38367405
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equal.
    Rezaee ME; Pallauf M; Fletcher SA; Pavlovich CP; Baraban E; Ged Y; Singla N
    Urol Oncol; 2024 Apr; 42(4):119.e23-119.e29. PubMed ID: 38355353
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
    Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
    Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry.
    Saitta C; Afari JA; Walia A; Patil D; Tanaka H; Hakimi K; Wang L; Meagher MF; Liu F; Nguyen MV; Puri D; Cerrato C; Saidian A; Kobayashi M; Fukuda S; Fujii Y; Master V; Derweesh IH
    Urol Oncol; 2024 Apr; 42(4):119.e1-119.e16. PubMed ID: 38341362
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis.
    Singhal T; Singh P; Parida GK; Agrawal K
    Ann Nucl Med; 2024 Mar; 38(3):176-187. PubMed ID: 38340144
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma.
    Li X; Deng X; Liu T; Zhang W; Tao J
    Aging (Albany NY); 2024 Feb; 16(4):3280-3301. PubMed ID: 38334964
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the "TOWARDS" Score.
    Ishiyama Y; Omae K; Kondo T; Yoshida K; Iizuka J; Takagi T
    Ann Surg Oncol; 2024 May; 31(5):3513-3522. PubMed ID: 38285306
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Growth kinetics of venous tumor thrombus in patients with renal cell carcinoma.
    Barashi NS; Friedman D; Shiang A; Pickersgill N; Vetter J; Suresh T; Ippolito JE; Smith ZL
    Urol Oncol; 2024 Feb; 42(2):31.e17-31.e23. PubMed ID: 38160126
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study.
    Nakano J; Urabe F; Kiuchi Y; Takamizawa S; Suzuki H; Kawano S; Miyajima K; Fukuokaya W; Takahashi K; Iwatani K; Imai Y; Kayano S; Aikawa K; Yanagisawa T; Tashiro K; Yuen S; Sato S; Tsuzuki S; Miki J; Kimura T;
    Int J Urol; 2024 Apr; 31(4):394-401. PubMed ID: 38151321
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Single-Port Robotic Radical Prostatectomy Using Transvesical and Transperineal Access in Patients with a Hostile Abdomen.
    Ferguson EL; Ramos-Carpinteyro R; Soputro N; Chavali JS; Geskin A; Kaouk JH
    J Endourol; 2024 Feb; 38(2):150-158. PubMed ID: 38069569
    [No Abstract]    [Full Text] [Related]  

  • 14. Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series.
    Clark CN; Smith J; Fuchs ME; Ching CB; DaJusta DG
    J Robot Surg; 2023 Dec; 17(6):3045-3048. PubMed ID: 37971637
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic impact of pre-referral tumor resection in unilateral Wilms tumor: A single-institute experience from a lower middle-income country.
    Khan MS; Maaz AUR; Qazi AQ; Aslam S; Riaz S; Malik AS; Shaheen N
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30760. PubMed ID: 37962283
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.
    Falagario UG; Abbadi A; Remmers S; Björnebo L; Bogdanovic D; Martini A; Valdman A; Carrieri G; Menon M; Akre O; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
    JAMA Netw Open; 2023 Sep; 6(9):e2332900. PubMed ID: 37695584
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Assessing the impact of lymphovascular invasion on overall survival in surgically treated renal cell carcinoma patients: A nationwide cohort analysis.
    Rakic I; Rakic N; Stephens A; Corsi N; Davis M; Tinsley S; Butaney M; Arora S; Sood A; Autorino R; Rogers C; Abdollah F
    Urol Oncol; 2023 Oct; 41(10):435.e1-435.e9. PubMed ID: 37625905
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
    Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
    [No Abstract]    [Full Text] [Related]  

  • 19. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
    Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
    Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma.
    Kümmerl L; Kraulich M; Lesyuk W; Binninger A; Goebell PJ; Kahlmeyer A
    Urol Oncol; 2023 Sep; 41(9):392.e1-392.e9. PubMed ID: 37442742
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 37.